- UHRA Home
- Browsing by Author
Browsing by Author "Clerici, Massimo"
Now showing items 1-5 of 5
-
Investigating the effectiveness and tolerability of intranasal esketamine among older adults with treatment-resistant depression (TRD): a post-hoc analysis from the REAL-ESK study group
d’Andre, Giacomo; S. McIntyre, Roger; Chiappini, Stefania; Stefanelli, Giulia; Carullo, Rosalba; Andriola, Ileana; Zanardi, Raffaella; Martiadis, Vassillis; L. Sensi, Stefano; Sani, Gabriele; Clerici, Massimo; Di Lorenzo, Giorgio; Vita, Antonio; Pettorruso, Mauro; Martinotti, Giovanni (2023-07-08)Introduction: Treatment-resistant depression (TRD) is a serious and debilitating psychiatric disorder that frequently affects older patients. Esketamine nasal spray (ESK-NS) has recently been approved as a treatment for ... -
Investigating the Role of Maintenance TMS Protocols for Major Depression: Systematic Review and Future Perspectives for Personalized Interventions
d’Andrea, Giacomo; Mancusi, Gianluca; Santovito, Maria Chiara; Marrangone, Carlotta; Martino, Fabrizio; Santorelli, Mario; Miuli, Andrea; Di Carlo, Francesco; Signorelli, Maria Salvina; Clerici, Massimo; Pettorruso, Mauro; Martinotti, Giovanni (2023-04-21)Repetitive Transcranial Magnetic Stimulation (rTMS) has been approved by the FDA as an effective intervention for Treatment-Resistant Depression (TRD). However, there is little evidence about maintenance protocol necessity. ... -
Knowledge and Use of Novel Psychoactive Substances in Italy: a Survey-Based Study in the General Population
Zangani, Caroline; Ostinelli, Edoardo Giuseppe; Giordano, Barbara; D’Agostino, Armando; Martinotti, Giovanni; Clerici, Massimo; Gambini, Orsola; Schifano, Fabrizio (2021-11-08)In this study, we aimed to identify the current trend of novel psychoactive substance (NPS) consumption in Italy and the level of knowledge about NPS in the general population and to explore the presence of risk factors ... -
Patterns of management of patients with dual disorder (psychosis) in Italy: a survey of psychiatrists and other physicians focusing on clinical practice
Clerici, Massimo; De Bartolomeis, Andrea; De Filippis, Sergio; Ducci, Giuseppe; maremmani, Icro; Martinotti, Giovanni; Schifano, Fabrizio (2018-11-13)Patients with severe psychotic disorders such as schizophrenia, schizoaffective and bipolar disorders frequently suffer from concomitant substance use disorders (SUDs) – Dual Disorder (DD) patients. In order to better ... -
Treating bipolar depression with esketamine: Safety and effectiveness data from a naturalistic multicentric study on esketamine in bipolar versus unipolar treatment‐resistant depression
the REAL‐ESK Study Group; Martinotti, Giovanni; Dell'Osso, Bernardo; Di Lorenzo, Giorgio; Maina, Giuseppe; Bertolino, Alessandro; Clerici, Massimo; Barlati, Stefano; Rosso, Gianluca; Di Nicola, Marco; Marcatili, Matteo; d'Andrea, Giacomo; Cavallotto, Clara; Chiappini, Stefania; De Filippis, Sergio; Nicolò, Giuseppe; De Fazio, Pasquale; Andriola, Ileana; Zanardi, Raffaella; Nucifora, Domenica; Di Mauro, Stefania; Bassetti, Roberta; Pettorruso, Mauro; McIntyre, Roger S.; Sensi, Stefano L.; di Giannantonio, Massimo; Vita, Antonio; Baldacci, Giulia; Belletti, Sandro; Bellomo, Antonello; Benatti, Beatrice; Carminati, Matteo; Carullo, Rosalba; de Berardis, Domenico; de Filippis, Renato; Chiaie, Roberto Delle; di Carlo, Francesco; Di Petta, Gilberto; Galluzzo, Alessandro; Giorgelli, Valentina; Lombardozzi, Ginevra; Martiadis, Vassilis; Mattei, Chiara; Mosca, Alessio; Niolu, Cinzia; Olivola, Miriam; Percudani, Mauro; Pepe, Maria; Rossi, Eros; Scardigli, Maria Ilaria; Tatì, Filippo (2023-01-18)Background: Bipolar depression accounts for most of the disease duration in type I and type II bipolar disorder (BD), with few treatment options, often poorly tolerated. Many individuals do not respond to first‐line ...